What is Rest EZ.?
Rest EZ. operates at the intersection of consumer health and biotechnology, specializing in the formulation of natural sleep aids. By utilizing a proprietary blend of L-Theanine, Melatonin, and Valerian root, the company addresses the growing consumer demand for non-pharmaceutical alternatives to traditional sleep management. Based in Riverton, UT, the firm has carved out a distinct niche by prioritizing ingredient transparency and efficacy, positioning itself as a high-growth player in the wellness industry. Their commitment to natural wellness aligns with broader market trends favoring holistic health solutions, providing a robust foundation for long-term brand loyalty and market share expansion.
How much funding has Rest EZ. raised?
Rest EZ. has raised a total of $20M across 1 funding round:
Stock Offering
$20M
Stock Issuance/Offering (2021): $20M, investors not publicly disclosed
Key Investors in Rest EZ.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Rest EZ.?
With the recent influx of capital, Rest EZ. is poised to execute a comprehensive growth strategy aimed at scaling its enterprise-level operations. The company is expected to focus on aggressive market expansion, potentially diversifying its product portfolio to include complementary wellness offerings. Furthermore, the strategic deployment of these funds will likely facilitate increased investment in research and development, allowing the firm to refine its existing formulations and maintain a competitive edge in the rapidly evolving sleep-aid market. As the company matures, stakeholders will be monitoring its ability to translate this financial momentum into sustained revenue growth and operational excellence within the broader health and wellness ecosystem.
See full Rest EZ. company page
